An example of candidate epigenetic silencing in the initiation and progression of leukaemogenesis involves CDKN2B. This region frequently undergoes loss of heterozygosity (LOH) in ALL [10,11]. The gene discussed is CDKN2B; the disease is acute lymphoblastic leukemia.